University of Rochester
This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treatment, they will follow up with their radiation oncologist.
Inclusion Criteria: * Histological confirmation of non-small cell cancer will not be required as primary goal of this phase II trial is to look at toxicity. However, all primary non-small cell lung cancers otherwise of following types are eligible: squamous cell carcinoma, adenocarcinoma, large cell carcinoma, bronchioalveolar cell carcinoma, or non-small cell carcinoma not otherwise specified. * Eligible patients must have appropriate staging studies identifying them as specific subsets of AJCC stage I or II based on only one of the following combinations of TNM staging: * T1, N0, M0 * T2 (≤…
Radiation therapy given in a 3 fraction schedule (over 3 days). Total dose is 54 Grays.
Radiation therapy given in 5 fractions (over 5 days). Total dose is 60 Grays.
Arctuva estimate
Verify or correct the compensation shown for this listing.